Roxee Medication Guide

Gentamicin Sulfate

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference complete FDA data linked Rx required Liquid (Solution) Multiple FDA sponsors Official label facts Owner quick guide first

Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Reference facts

Reference refreshed

Aug 6, 2026, 7:47 p.m.

These are the reference facts Roxee uses on browse cards and quick facts.

FDA applications

FDA application data refreshed

Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports

Safety data refreshed

Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details

Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC

Illustration placeholder

Gentamicin Sulfate

Drug type: Generic ingredient • Generic profile • No FDA branded products linked

Both Liquid (Solution) Rx required 100% reference complete

Species: Both

Manufacturer: Multiple FDA sponsors

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Gentamicin Sulfate

For treatment of external eye infections and inflammation in dogs. For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (tonsillitis, pneumonia, tracheobronchitis), skin and soft tissue (pyodermatitis, wounds, lacerations, peritonitis). For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (pneumonitis pneumonia, upper respiratory tract infections), skin and soft tissue (wounds, lacerations, peritonitis), and as supportive therapy for secondary bacterial infections associated with panleucopenia. Species commonly shown: Both, Poults 1 to 3 Day Old, 1 day-old broiler chicks.

Generic name

Gentamicin Sulfate

Brand names

Garasol®, Gentamicin Sulfate Solution 100 mg/ml, Legacy Sterile Solution Gentamicin Sulfate Solution, Gentaglyde™ Solution

Manufacturer

Multiple FDA sponsors

Species

Both, Poults 1 to 3 Day Old, 1 day-old broiler chicks, Horse

Dosage forms

Liquid (Solution), Soluble Powder, Ointment, Injection

Prescription

Prescription required

Completeness

100%

Validation

Needs review

Brand names

Garasol® Gentamicin Sulfate Solution 100 mg/ml Legacy Sterile Solution Gentamicin Sulfate Solution Gentaglyde™ Solution Gentamex™ 100 GentaMax® 100 GentaPoult Genta-Ject® Gentamicin Sulfate Pig Pump Oral Solution GEN-GARD® Gentasol Vetro-Gen™ Veterinary Ophthalmic Ointment Gentamicin Piglet Injection Gentamicin Sulfate Solution GentaMed™-P GentaMed™ Gentamicin Sulfate Ophthalmic Solution

Dosage forms

Liquid (Solution) Soluble Powder Ointment Injection Ophthalmic Solution

Indications / Uses

Warnings / Contraindications

If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Loss of hearing, Lack of efficacy - NOS, Vomiting, Deafness, Lack of efficacy (bacteria) - NOS, Lethargy (see also Central nervous system depression in Neurological).

FAQ

Both, Poults 1 to 3 Day Old, 1 day-old broiler chicks, Horse, Mares, Not For Food, Neonate or suckling, Weanling, Eggs, excluding eggs for human consumption, Dog, Cat, 1 to 3 days old, 1 day old chicks

Yes. Roxee shows this as prescription-only.

Liquid (Solution), Soluble Powder, Ointment, Injection

Related Conditions

Conjunctivitis Metritis Pica Pneumonia (aspiration, bacterial, viral) Pyoderma (superficial/deep)

Source Transparency

Verified source: https://www.roxee.ai/meds/
Verified source: https://animaldrugsatfda.fda.gov
Verified source: https://api.fda.gov/animalandveterinary/event.json
Verified source: https://www.roxee.ai/conditions/
Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1976
Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1225
Last refreshed: Aug 6, 2026, 7:47 p.m.
Last verified: Apr 15, 2026, 10:04 a.m.
Validation status: Needs review

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested
Not for use in horses intended for food
Fluid in abdomen NOS (1 reports)
Facial swelling (1 reports)
Eosinopenia (1 reports)

When to call the vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.
Facial swelling or hives.
Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

Is this medicine the right fit for my pet’s current symptoms?
Which warning signs mean I should call back right away?
How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Gentamicin Sulfate; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA case USA-USFDACVM-2026-US-008429

Safety signal coverage Reported signals

32 tracked reaction signals; 32 reported cases; 23 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA case USA-USFDACVM-2026-US-008429

Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA case USA-USFDACVM-2026-US-008429

Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Fluid in abdomen NOS (1 reports), Facial swelling (possible allergy) (1 reports), Eosinopenia (1 reports), Enlarged lymph node (1 reports), Elevated total bilirubin (1 reports)

Body systems represented Signal grouping

Digestive (5), Skin & allergy (2), Other (25)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (22 reports), Cat (10 reports)

Breed metadata in reports Metadata only

Retriever - Labrador (3), ['Retriever - Golden', 'Poodle - Standard'] (1), ['Retriever - Labrador', 'Crossbred Canine/dog'] (1), Domestic Shorthair (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Gentamicin Sulfate fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should b, Not for use in horses intended for food, Fluid in abdomen NOS, Facial swelling, Eosinopenia

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Gentamicin Sulfate brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.

Vet source depth

openFDA case USA-USFDACVM-2026-US-008429 · adverse_reaction · adverse reactions
Contraindication source · fda_animal_drugs · warnings contraindications
FDA application profile · official_label · quick facts
FDA application profile · official_label · quick facts
Medication usage source · fda_animal_drugs · quick facts
FOI · document · documents
EA · document · documents
FONSI · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Sources:

FDA application profile · official_label
FDA application profile · official_label
Medication usage source · fda_animal_drugs
Gentamicin Sulfate Ophthalmic Solution · official_label
openFDA case USA-USFDACVM-2026-US-008429 · adverse_reaction

Safety & side effects

Side effects to monitor:

If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested
Not for use in horses intended for food
Fluid in abdomen NOS
Facial swelling
Eosinopenia

Most reported reactions:

Fluid in abdomen NOS (1 reports)
Facial swelling (possible allergy) (1 reports)
Eosinopenia (1 reports)

Explore reported case details

Emergency warning signs:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species

1 day old chicks, 1 day-old broiler chicks, 1 to 3 days old, Cat, Dog, Eggs, Horse, Neonate or suckling, Poults 1 to 3 Day Old, Weanling

Indication / use

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Form / route / dose

Form: Injection, Liquid (Solution), Ointment, Ophthalmic Solution, Soluble Powder
Route: Immersion, Intramuscular, Intrauterine, Ophthalmic, Oral, Subcutaneous, Topical
Confirm product label and patient-specific plan.

Warnings

High: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal…

Adverse-event caveat

openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Source docs

101-862 Official label / PI
101-862 Official label / PI
Garasol® SPL

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both

Manufacturer: Multiple FDA sponsors

Form: Injection, Liquid (Solution), Ointment, Ophthalmic Solution, Soluble Powder

Identifiers:

ANADA: 200023 ANADA: 200037 ANADA: 200102 ANADA: 200115 ANADA: 200137 ANADA: 200147 ANADA: 200174 ANADA: 200183 ANADA: 200185 ANADA: 200188 ANADA: 200190 ANADA: 200191 ANADA: 200229 ANADA: 200273 ANADA: 200283 ANADA: 200287 ANADA: 200388 ANADA: 200394 ANADA: 200395 ANADA: 200415

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/101862 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200147 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source

Warnings / Contraindications

High: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Source metadata:

https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters

openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Stored reports

Matching reports

Active filters

Selected filters

Reaction: Lymphopenia Clear

Species

Breed

Size / weight

Age

Sex

Seriousness

Outcome

Reaction

Body system

Region

Received after

Received before

Reset

Drill into common report signals

Lack of efficacy (endoparasite) - heartworm (2) Lymphopenia (2) Abnormal radiograph finding (1) Abnormal ultrasound finding (1) Other (7) Digestive (3) Effectiveness (3) Skin & allergy (2)

Showing up to 50 matching reports.

USA-USFDACVM-2026-US-008429

Received 2026-02-25 · MSK · MSK

Non-serious

Species: Dog
Breed: ['Retriever - Golden', 'Poodle - Standard']
Size / weight: 50-99 lb (25.49 Kilogram)
Age: 1-3 years (1.08 Year)
Sex: Unknown Unknown
Region: USA
Reactions: CoughHeavy breathingRespiratory soundAbnormal radiograph findingEosinophiliaLymphopeniaBasophiliaMonocytosis
Body systems: Other
Outcomes: Ongoing

USA-USFDACVM-2025-US-071623

Received 2025-12-01 · MSK · MSK

Serious

Species: Dog
Breed: ['Retriever - Labrador', 'Dog (unknown)']
Size / weight: 25-49 lb (17.69 Kilogram)
Age: 8+ years (12 Year)
Sex: Male Neutered
Region: USA
Reactions: VomitingNot eatingWeight lossIcterusLeucopenia NOSDecreased red blood cell countThrombocytopeniaElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)Elevated total bilirubinHigh pancreatic-specific lipaseUrinary incontinenceInfectious disease NOSOverdoseGall bladder & bile duct disorder NOSLymphopeniaNeutropeniaSplenomegalyLoose stoolPancreas disorderHepatomegalyDeath by euthanasiaHypoalbuminaemiaHypoproteinaemiaFluid in abdomen NOSElevated blood urea nitrogen (BUN)Elevated bile acidsAbnormal ultrasound findingElevated cholesterol (total)Enlarged lymph node (localised)Reduced globulinsMonocytopeniaEosinopeniaLiver nodules
Body systems: DigestiveOther
Outcomes: Euthanized

Tap or hover a reaction to see what it means in plain language.

Tracked signals

Reported cases

Serious reports

Species represented

Grouped by Body System

Digestive (5) · Loss of appetite, Diarrhea, Decreased appetite Skin & allergy (2) · Facial swelling (possible allergy), Chewing - pruritus Other (25) · Fluid in abdomen NOS, Eosinophilia, Eosinopenia

Most Reported Reactions

Body system	Cases	Species	Serious cases
Other	1	Dog	1
Skin & allergy	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1

Species coverage: Dog (22) Cat (10)

View detailed reaction table

Body system	Species	Seriousness	Frequency	Reports
Digestive	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Skin & allergy	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Digestive	Cat	Serious	-	1
Other	Dog	Serious	-	1
Digestive	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Skin & allergy	Dog	Non-serious	-	1
Digestive	Cat	Serious	-	1
Digestive	Cat	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Dog	Non-serious	-	1
Other	Cat	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1

Source metadata:

https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2026-US-008429

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

101-862 Official label / PI · EA 101-862 Official label / PI · FONSI Garasol® SPL · SPL

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

No owner handouts linked yet.

Official label / PI

SPL

FOI

101-862

Official label / PI · EA

Open original

101-862

Official label / PI · FONSI

Open original

Garasol®

SPL · SPL

Open original

FDA Structured Product Label

Garasol®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 101-862
Status: RX
Form: Liquid (Solution)
Route: Subcutaneous
Species: Poults 1 to 3 Day Old • 1 day-old broiler chicks

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 50 or 100 milligrams of gentamicin.

Chickens (day-old)

Indication

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Dosage

0.2 milligram of gentamicin per 0.2 milliliter dose, using a 50 milligram-per-milliliter solution diluted with sterile physiological saline to 1.0 milligram per milliliter. Administer aseptically injecting the diluted product subcutaneously in the neck.

Limitations

For use in day-old chickens only. Do not slaughter treated animals for food for at least 5 weeks after treatment.

Turkeys (1- to 3-day-old poults)

Indication

As an aid in the prevention of early mortality due to Arizona paracolon infections susceptible to gentamicin sulfate.

Dosage

One milligram of gentamicin per poult, using a 5 milligram-per-milliliter solution. Administer subcutaneously in the neck.

Limitations

Injected poults must not be slaughtered for food for at least 9 weeks after treatment.

GentaPoult

SPL · SPL

Open original

FDA Structured Product Label

GentaPoult Genta-Ject®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-147
Status: RX
Form: Liquid (Solution)
Route: Subcutaneous
Species: Poults 1 to 3 Day Old • 1 day-old broiler chicks

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 100 milligrams of gentamicin.

Turkeys (1 to 3 day old poults)

Indication

As an aid in the prevention of early mortality due to Arizona paracolon infections susceptible to gentamicin.

Dosage

One milligram of gentamicin per 0.2 milliliter dose, using the 50-100-milligrams-per-milliliter product diluted with sterile saline to a concentration of 5 milligrams-per-milliliter.

Limitations

For 1 to 3 day old turkey poults. Administer subcutaneously in the neck. Injected poults must not be slaughtered for food for at least 9 weeks after treatment.

Chickens (day-old)

Indication

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Dosage

0.2 milligram of gentamicin per 0.2 milliliter dose, using a 50 milligram-per-milliliter solution diluted with sterile physiological saline to 1.0 milligram per milliliter.

Limitations

Do not slaughter treated animals for food for at least 5 weeks after treatment. Administer aseptically injecting the diluted product subcutaneously in the neck.

Genta-Ject®

SPL · SPL

Open original

FDA Structured Product Label

GentaPoult Genta-Ject®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-147
Status: RX
Form: Liquid (Solution)
Route: Subcutaneous
Species: Poults 1 to 3 Day Old • 1 day-old broiler chicks

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 100 milligrams of gentamicin.

Turkeys (1 to 3 day old poults)

Indication

As an aid in the prevention of early mortality due to Arizona paracolon infections susceptible to gentamicin.

Dosage

One milligram of gentamicin per 0.2 milliliter dose, using the 50-100-milligrams-per-milliliter product diluted with sterile saline to a concentration of 5 milligrams-per-milliliter.

Limitations

For 1 to 3 day old turkey poults. Administer subcutaneously in the neck. Injected poults must not be slaughtered for food for at least 9 weeks after treatment.

Chickens (day-old)

Indication

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Dosage

0.2 milligram of gentamicin per 0.2 milliliter dose, using a 50 milligram-per-milliliter solution diluted with sterile physiological saline to 1.0 milligram per milliliter.

Limitations

Do not slaughter treated animals for food for at least 5 weeks after treatment. Administer aseptically injecting the diluted product subcutaneously in the neck.

Gentamicin Sulfate Ophthalmic Solution

SPL · SPL

Open original

FDA Structured Product Label

Gentamicin Sulfate Ophthalmic Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Domes Pharma S.A.
ANADA: 200-576
Status: RX
Form: Ophthalmic Solution
Route: Ophthalmic
Species: Dog • Cat

Composition / specifications

Gentamicin sulfate equivalent to 3.0 mg gentamicin per mL of solution

Label highlights

Indication

For the topical treatment of conjunctivitis caused by susceptible bacteria in dogs and cats

Dosage

Instill 1 or 2 drops into the conjunctival sac 2 to 4 times a day

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

Gentasol

SPL · SPL

Open original

FDA Structured Product Label

Gentasol

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Med-Pharmex, Inc.
ANADA: 200-191
Status: OTC
Form: Liquid (Solution)
Route: Immersion
Species: Eggs

Composition / specifications

Each milliliter of solution contains gentamicin sulfate equivalent to 50 milligrams of gentamicin base.

Turkey (eggs)

Indication

The drug is recommended as an aid in the reduction or elimination of the following microorganisms from turkey-hatching eggs: Arizona hinshawii (paracolon), Salmonella st. paul, and Mycoplasma meleagris.

Dosage

The drug is added to clean water to provide a dip solution with a gentamicin concentration of 250 to 1,000 parts per million. A concentration of 500 parts per million is recommended. Clean eggs should be held submerged in the gentamicin solution under a vacuum of about 27.5 to 38 centimeters of mercury for 5 minutes followed by additional soaking in gentamicin solution for approximately 10 minutes at atmospheric pressure. Eggs can also be treated by warming them for 3 to 4 hours at approximately 40 degrees F, keeping eggs submerged for 10- 15 minutes.

Limitations

For use in the dipping treatment of turkey-hatching eggs only. Eggs which have been dipped in the drug shall not be used for food.

GentaMed™-P

SPL · SPL

Open original

FDA Structured Product Label

GentaMed™-P

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Ltd.
ANADA: 200-468
Status: RX
Form: Injection
Route: Subcutaneous
Species: Poults 1 to 3 Day Old • 1 day old chicks

Chickens

Indication

For the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa susceptible to gentamicin sulfate.

Dosage

0.2 milligram of gentamicin per 0.2 milliliter dose.

Turkeys

Indication

As an aid in the prevention of early mortality of 1 to 3-day-old turkeys associated with Arizona paracolon infections susceptible to gentamicin sulfate.

Dosage

One (1) milligram of gentamicin per 0.2 milliliter dose.

Gentamicin Piglet Injection

SPL · SPL

Open original

FDA Structured Product Label

Gentamicin Piglet Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Sparhawk Laboratories, Inc.
ANADA: 200-394
Status: RX
Form: Liquid (Solution)
Route: Intramuscular
Species: 1 to 3 days old

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 5 milligrams of gentamicin.

Swine

Indication

In piglets up to 3 days old for treatment of porcine colibacillosis caused by strains of E. coli sensitive to gentamicin

Dosage

5 milligrams of gentamicin as a single intramuscular dose using 5 milligram-per-milliliter solution.

Limitations

For single intramuscular dose in pigs up to 3 days of age only. Do not slaughter treated animals for food for at least 40 days following treatment

Gentamicin Sulfate Pig Pump Oral Solution

SPL · SPL

Open original

FDA Structured Product Label

Gentamicin Sulfate Pig Pump Oral Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-174
Status: RX
Form: Liquid (Solution)
Route: Oral
Species: Neonate or suckling

Composition / specifications

Each milliliter of pig pump oral solution contains gentamicin sulfate equivalent to 5 milligrams of gentamicin.

Swine (neonatal, 1 to 3 days of age)

Indication

For the control and treatment of colibacillosis in neonatal pigs 1-3 days of age, caused by strains of E. coli sensitive to gentamicin.

Dosage

Administer 1 mL of pig pump oral solution (5 mg of gentamicin) orally per pig one time.

Vetro-Gen™ Veterinary Ophthalmic Ointment

SPL · SPL

Open original

FDA Structured Product Label

Vetro-Gen™ Veterinary Ophthalmic Ointment

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Dechra Veterinary Products LLC
ANADA: 200-273
Status: OTC
Form: Ointment
Route: Topical
Species: Dog • Cat

Composition / specifications

Each gram of sterile ointment contains gentamicin sulfate equivalent to 3 milligrams of gentamicin.

Dogs

Indication

The drug is used for topical treatment of conjunctivitis caused by susceptible bacteria.

Dosage

Apply approximately a 1/2 inch strip to the affected eye 2 to 4 times a day.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication

The drug is used for topical treatment of conjunctivitis caused by susceptible bacteria.

Dosage

Apply approximately a 1/2 inch strip to the affected eye 2 to 4 times a day.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

GentaMed™

SPL · SPL

Open original

FDA Structured Product Label

GentaMed™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Ltd.
ANADA: 200-494
Status: RX
Form: Soluble Powder
Route: Oral

Composition / specifications

Each gram of gentamicin sulfate soluble powder contains gentamicin sulfate equivalent to 333.3 milligrams of gentamicin. 120 grams of gentamicin per 360 gram jar.

Swine (weanling)

Indication

For the control and treatment of colibacillosis in weaning swine caused by strains of Escherichia coli sensitive to gentamicin.

Dosage

25 mg gentamicin per gallon (1 level scoop/240 gallons) of drinking water, for three consecutive days to provide 0.5 mg/lb/day. (Note: the jar contains a scoop that provides approximately 18 g of product when level full.) For proportioner use, add 1 level scoop to 2 gallons stock solution and dispense at the rate of 1 oz/gal drinking water (25 mg/gal).

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Swine

Indication

For the control and treatment of swine dysentery associated with Treponema hyodysenteriae.

Dosage

50 mg gentamicin per gallon (1 level scoop/120 gallons) for three consecutive days to ensure a gentamicin dosage of approximately 1.0 mg/lb/day. (Note: the jar contains a scoop that provides approximately 18 g of product when level full.)

For proportioner use, add 1 level scoop to 1 gallons stock solution and dispense at the rate of 1 oz/gal drinking water (50 mg/gal).

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Gentamex™ 100

SPL · SPL

Open original

FDA Structured Product Label

Gentamex™ 100

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Ltd.
ANADA: 200-115
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

The drug is indicated for use for control of bacterial infections of the uterus in horses (metritis) and as an aid in improving conception in mares with uterine infections caused by bacteria sensitive to gentamicin.

Dosage

It is administered at a dosage level of 2 to 2.5 grams per day for 3 to 5 days during estrus, each dose being diluted with 200 to 500 milliliters of sterile physiological saline before aseptic infusion into the uterus.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

GEN-GARD®

SPL · SPL

Open original

FDA Structured Product Label

GEN-GARD®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-185
Status: RX
Form: Soluble Powder
Route: Oral
Species: Weanling

Composition / specifications

Each gram of gentamicin sulfate soluble powder contains gentamicin sulfate equivalent to 333.3 milligrams of gentamicin.

Swine (weanling)

Indication

For control and treatment of colibacillosis in weanling swine caused by strains of Escherichia coli sensitive to gentamicin.

Dosage

Administer gentamicin sulfate equivalent to 25 milligrams of gentamicin per gallon of drinking water to provide 0.5 milligram per pound of body weight per day for 3 consecutive days.

Limitations

For use in swine drinking water only. Do not store or offer medicated drinking water in rusty containers since the drug is quickly destroyed in such containers. Medicated drinking water should be prepared daily and be the sole source of drinking water for 3 consecutive days. Do not slaughter treated swine for food for at least 10 days following treatment. Federal Law restricts this drug to use by or on the order of a licensed veterinarian.

Swine

Indication

For control and treatment of swine dysentery associated with Brachyspira hyodysenteriae.

Dosage

Administer gentamicin sulfate equivalent to 50 milligrams of gentamicin per gallon of drinking water to provide 1.0 milligram per pound of body weight per day for 3 consecutive days. Treatment may be repeated if dysentery recurs.

Limitations

Legacy Sterile Solution

SPL · SPL

Open original

FDA Structured Product Label

Legacy Sterile Solution Gentamicin Sulfate Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-037
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

Gentamicin Sulfate Solution

SPL · SPL

Open original

FDA Structured Product Label

Legacy Sterile Solution Gentamicin Sulfate Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-037
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

GentaMax® 100

SPL · SPL

Open original

FDA Structured Product Label

GentaMax® 100

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Elanco US Inc.
ANADA: 200-137
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

Gentamicin Sulfate Solution 100 mg/ml

SPL · SPL

Open original

FDA Structured Product Label

Gentamicin Sulfate Solution 100 mg/ml

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Cronus Pharma Specialities India Private Ltd.
ANADA: 200-023
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption

Gentaglyde™ Solution

SPL · SPL

Open original

FDA Structured Product Label

Gentaglyde™ Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Zoetis Inc.
ANADA: 200-102
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

Gentamicin Sulfate Solution

SPL · SPL

Open original

FDA Structured Product Label

Gentamicin Sulfate Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Sparhawk Laboratories, Inc.
ANADA: 200-395
Status: RX
Form: Liquid (Solution)
Route: Intrauterine
Species: Horse

Composition / specifications

Each milliliter of the drug contains 50 or 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses

https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1622 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadEA/116 · document · EA
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFonsi/118 · document · FONSI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1592/Garasol%C2%AE · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/988 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1976 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/326/GentaPoult · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/325/Genta-Ject%C2%AE · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1252 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2348/Gentamicin%20Sulfate%20Ophthalmic%20Solution · document · SPL

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness

Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC

Official (FDA)

Identity: Generic ingredient • No FDA branded products linked

No official FDA brand rows linked yet for this ingredient.

Case-reported brands (openFDA): MSK

Catalog species: Both • FDA-labeled species: 1 day old chicks, 1 day-old broiler chicks, 1 to 3 days old, Cat, Dog, Eggs, Horse, Neonate or suckling, Poults 1 to 3 Day Old, Weanling

Rx/OTC: OTC, RX

Form/route: Injection, Liquid (Solution), Ointment, Ophthalmic Solution, Soluble Powder • Immersion, Intramuscular, Intrauterine, Ophthalmic, Oral, Subcutaneous, Topical

Applications: NADA 101-862 • ANADA 200-147 • ANADA 200-576 • ANADA 200-191 • ANADA 200-468 • ANADA 200-394 • ANADA 200-174 • ANADA 200-273 • ANADA 200-494 • ANADA 200-115 • ANADA 200-185 • ANADA 200-037 • ANADA 200-137 • ANADA 200-023 • ANADA 200-102 • ANADA 200-395

Documents: 19 (FOI: 17) • SPL: 18 • Label highlights • Official documents

Safety (openFDA)

Top reactions: Dog 63 • Cat 2 • View

Case summaries: 8 (showing 8) • View

openFDA reports are unverified and do not prove causation.

Explore

Related conditions: Conjunctivitis Metritis Pica Pneumonia (aspiration, bacterial, viral) Pyoderma (superficial/deep)

Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)

Diagnosis Codes

ICD10_CM: H60.90

Otitis externa, unspecified ear

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points

If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)

Top reaction signals

Fluid in abdomen NOS (1) Facial swelling (possible allergy) (1) Eosinopenia (1) Enlarged lymph node (1) Elevated total bilirubin (1) Elevated serum alkaline phosphatase (1) Elevated cholesterol (1) Elevated blood urea nitrogen (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers

Package NDC	Product NDC	Status
0061-0100-01	0061	-
0061-0134-01	0061	-
0061-0387-01	0061	-
0061-0387-02	0061	-
0061-0387-03	0061	-
0061-0387-08	0061	-
0061-0387-17	0061	-
0061-1246-01	0061	-
0061-1246-02	0061	-
0061-1246-04	0061	-
0061-1246-05	0061	-
11695-4153-1	11695	-
11695-4153-2	11695	-
11695-7009-1	11695	-
11695-7009-2	11695	-
11695-7009-3	11695	-
13985-566-12	13985	-
13985-566-24	13985	-
13985-566-60	13985	-
13985-701-07	13985	-

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

A200229_Orig_4_4_1998.pdf • FOI summary • Official • Feb. 27, 2026
FDA FOI summary for application 200229
UCM061643.pdf • FOI summary • Official • Feb. 27, 2026
FDA FOI summary for application 200229
A200188_Org_1_29_97.pdf • FOI summary • Official • Feb. 27, 2026
FDA FOI summary for application 200188
A200183_Org_7_31_1995.pdf • FOI summary • Official • Feb. 27, 2026
FDA FOI summary for application 200183
N101862_Supp_3_28_1996(2).pdf • FOI summary • Official • Feb. 3, 2026
FDA FOI summary for application 101862
ucm117265.pdf • FOI summary • Official • Dec. 3, 2025
FDA FOI summary for application 141177
ucm117268.pdf • FOI summary • Official • Dec. 3, 2025
FDA FOI summary for application 141177
ucm117269.pdf • FOI summary • Official • Dec. 3, 2025
FDA FOI summary for application 141177
A200147_Orig_4_10_1995.pdf • FOI summary • Official • July 3, 2024
FDA FOI summary for application 200147
ucm061600.pdf • FOI summary • Official • July 3, 2024
FDA FOI summary for application 200147
UCM287927.pdf • FOI summary • Official • May 14, 2024
FDA FOI summary for application 141330
UCM433786.pdf • FOI summary • Official • Dec. 14, 2023
FDA FOI summary for application 200576
A200191_Org_3_24_1997.pdf • FOI summary • Official • Aug. 25, 2023
FDA FOI summary for application 200191
UCM396874.pdf • FOI summary • Official • April 26, 2023
FDA FOI summary for application 200468
ucm061343.pdf • FOI summary • Official • April 26, 2023
FDA FOI summary for application 200394
A200174_Org_4_10_1997.pdf • FOI summary • Official • April 26, 2023
FDA FOI summary for application 200174
ucm061701.pdf • FOI summary • Official • Oct. 1, 2019
FDA FOI summary for application 200273
UCM167677.pdf • FOI summary • Official • Oct. 1, 2019
FDA FOI summary for application 200388
UCM292012.pdf • FOI summary • Official • Oct. 2, 2018
FDA FOI summary for application 200494
A200115_Orig_7_21_1995.pdf • FOI summary • Official • Oct. 2, 2018
FDA FOI summary for application 200115
A200185_Org_4_30_1997.pdf • FOI summary • Official • July 2, 2018
FDA FOI summary for application 200185
A200037_Org_2_8_1993.pdf • FOI summary • Official • July 2, 2018
FDA FOI summary for application 200037
A200137_Orig_11_13_1996.pdf • FOI summary • Official • June 19, 2018
FDA FOI summary for application 200137
A200023_Org_8_4_1995.pdf • FOI summary • Official • Feb. 1, 2018
FDA FOI summary for application 200023
A200102_Orig_05_19_1994.pdf • FOI summary • Official • July 19, 2017
FDA FOI summary for application 200102
N140896_Org_6_9_1993.pdf • FOI summary • Official • May 17, 2017
FDA FOI summary for application 140896
UCM504539.pdf • FOI summary • Official • Aug. 16, 2016
FDA FOI summary for application 200536
ucm061346.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200395
UCM292007.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200416
ucm061352.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200415
ucm061714.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200287
ucm061715.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200287
ucm061716.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200287
ucm061711.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 200283
UCM436590.pdf • FOI summary • Official • June 1, 2016
FDA FOI summary for application 34267

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 146 Clinical 9 Manufacturer 0 Marketing 0

Current Field Facts

contraindications: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on… (Clinical, 2026-04-16)
contraindications: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on… (Clinical, 2026-04-15)
contraindications: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on… (Clinical, 2026-04-11)
monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
side_effects: Top reported reactions (openFDA): Loss of hearing, Lack of efficacy - NOS, Vomiting, Deafness, Lack of efficacy (bacteria) - NOS, Lethargy (see also Central ne… (Clinical, 2026-04-11)
usage: For treatment of external eye infections and inflammation in dogs. For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (t… (Clinical, 2026-04-16)
usage: For treatment of external eye infections and inflammation in dogs. For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (t… (Clinical, 2026-04-15)
usage: For treatment of external eye infections and inflammation in dogs. For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (t… (Clinical, 2026-04-11)
contraindications: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on… (Official, 2026-04-22)
contraindications: If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on… (Official, 2026-02-12)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-08-06)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-08-05)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-08-04)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-08-03)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-08-02)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-08-01)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-07-31)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-07-30)
indications: Chickens: Gentamed™-P for Poultry Injection is recommended for the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonel… (Official, 2026-07-29)

Recent Revisions

side_effects updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
monitoring updated 2026-04-16 13:29 by curated_loader • Clinical monitoring context for feline diabetes management.
usage updated 2026-04-16 13:29 by curated_loader • Usage statement from FDA warning letter and approved-product context.
drug_profile_type updated 2026-04-16 13:29 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
manufacturer_name updated 2026-04-16 13:29 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
brand_names updated 2026-04-16 13:29 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
approval_reference updated 2026-04-16 13:29 by curated_loader • Official FDA application reference for Senvelgo.
side_effects updated 2026-04-16 10:08 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-16 10:08 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-04-16 10:08 by etl_backfill • Backfilled from existing medication fields
monitoring updated 2026-04-16 10:08 by curated_loader • Clinical monitoring context for feline diabetes management.
usage updated 2026-04-16 10:08 by curated_loader • Usage statement from FDA warning letter and approved-product context.
drug_profile_type updated 2026-04-16 10:08 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
manufacturer_name updated 2026-04-16 10:08 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
brand_names updated 2026-04-16 10:08 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
approval_reference updated 2026-04-16 10:08 by curated_loader • Official FDA application reference for Senvelgo.
side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product	Sponsor	Application	Status	Published
Garasol® RX Gentamicin Sulfate Liquid (Solution) • Subcutaneous Label highlights Official documents	Intervet, Inc.	NADA 101-862	Approved	Feb 3, 2026
GentaPoult Genta-Ject® RX Gentamicin Sulfate Liquid (Solution) • Subcutaneous Label highlights Official documents	Huvepharma EOOD	ANADA 200-147	Approved	Jul 3, 2024
Gentamicin Sulfate Ophthalmic Solution RX Gentamicin Sulfate Ophthalmic Solution • Ophthalmic Label highlights Official documents	Domes Pharma S.A.	ANADA 200-576	Approved	Dec 14, 2023
Gentasol OTC Gentamicin Sulfate Liquid (Solution) • Immersion Label highlights Official documents	Med-Pharmex, Inc.	ANADA 200-191	W	Aug 25, 2023
GentaMed™-P RX Gentamicin Sulfate Injection • Subcutaneous Label highlights Official documents	Bimeda Animal Health Ltd.	ANADA 200-468	Approved	Apr 26, 2023
Gentamicin Piglet Injection RX Gentamicin Sulfate Liquid (Solution) • Intramuscular Label highlights Official documents	Sparhawk Laboratories, Inc.	ANADA 200-394	Approved	Apr 26, 2023
Gentamicin Sulfate Pig Pump Oral Solution RX Gentamicin Sulfate Liquid (Solution) • Oral Label highlights Official documents	Huvepharma EOOD	ANADA 200-174	Approved	Apr 26, 2023
Vetro-Gen™ Veterinary Ophthalmic Ointment OTC Gentamicin Sulfate Ointment • Topical Label highlights Official documents	Dechra Veterinary Products LLC	ANADA 200-273	Approved	Oct 1, 2019
GentaMed™ RX Gentamicin Sulfate Soluble Powder • Oral Label highlights Official documents	Bimeda Animal Health Ltd.	ANADA 200-494	Approved	Oct 2, 2018
Gentamex™ 100 RX Gentamicin Sulfate Liquid (Solution) • Intrauterine Label highlights Official documents	Bimeda Animal Health Ltd.	ANADA 200-115	Approved	Oct 2, 2018
GEN-GARD® RX Gentamicin Sulfate Soluble Powder • Oral Label highlights Official documents	Huvepharma EOOD	ANADA 200-185	Approved	Jul 2, 2018
Legacy Sterile Solution Gentamicin Sulfate Solution RX Gentamicin Sulfate Liquid (Solution) • Intrauterine Label highlights Official documents	Huvepharma EOOD	ANADA 200-037	Approved	Jul 2, 2018
GentaMax® 100 RX Gentamicin Sulfate Liquid (Solution) • Intrauterine Label highlights Official documents	Elanco US Inc.	ANADA 200-137	Approved	Jun 19, 2018
Gentamicin Sulfate Solution 100 mg/ml RX Gentamicin Sulfate Liquid (Solution) • Intrauterine Label highlights Official documents	Cronus Pharma Specialities India Private Ltd.	ANADA 200-023	Approved	Feb 1, 2018
Gentaglyde™ Solution RX Gentamicin Sulfate Liquid (Solution) • Intrauterine Label highlights Official documents	Zoetis Inc.	ANADA 200-102	Approved	Jul 19, 2017
Gentamicin Sulfate Solution RX Gentamicin Sulfate Liquid (Solution) • Intrauterine Label highlights Official documents	Sparhawk Laboratories, Inc.	ANADA 200-395	Approved	Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Poults 1 to 3 Day Old • 1 day-old broiler chicks

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 50 or 100 milligrams of gentamicin.

Chickens (day-old)

Indication

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Dosage

Limitations

For use in day-old chickens only. Do not slaughter treated animals for food for at least 5 weeks after treatment.

Turkeys (1- to 3-day-old poults)

Indication

As an aid in the prevention of early mortality due to Arizona paracolon infections susceptible to gentamicin sulfate.

Dosage

One milligram of gentamicin per poult, using a 5 milligram-per-milliliter solution. Administer subcutaneously in the neck.

Limitations

Injected poults must not be slaughtered for food for at least 9 weeks after treatment.

FDA page: Open in Animal Drugs @ FDA

Species: Poults 1 to 3 Day Old • 1 day-old broiler chicks

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 100 milligrams of gentamicin.

Turkeys (1 to 3 day old poults)

Indication

As an aid in the prevention of early mortality due to Arizona paracolon infections susceptible to gentamicin.

Dosage

One milligram of gentamicin per 0.2 milliliter dose, using the 50-100-milligrams-per-milliliter product diluted with sterile saline to a concentration of 5 milligrams-per-milliliter.

Limitations

For 1 to 3 day old turkey poults. Administer subcutaneously in the neck. Injected poults must not be slaughtered for food for at least 9 weeks after treatment.

Chickens (day-old)

Indication

For prevention of early mortality caused by Escherichia coli. Salmonella typhimurium, and Pseudomonas aeruginosa that are susceptible to gentamicin.

Dosage

0.2 milligram of gentamicin per 0.2 milliliter dose, using a 50 milligram-per-milliliter solution diluted with sterile physiological saline to 1.0 milligram per milliliter.

Limitations

Do not slaughter treated animals for food for at least 5 weeks after treatment. Administer aseptically injecting the diluted product subcutaneously in the neck.

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

Gentamicin sulfate equivalent to 3.0 mg gentamicin per mL of solution

Label highlights

Indication

For the topical treatment of conjunctivitis caused by susceptible bacteria in dogs and cats

Dosage

Instill 1 or 2 drops into the conjunctival sac 2 to 4 times a day

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Eggs

Composition / specifications

Each milliliter of solution contains gentamicin sulfate equivalent to 50 milligrams of gentamicin base.

Turkey (eggs)

Indication

Dosage

Limitations

For use in the dipping treatment of turkey-hatching eggs only. Eggs which have been dipped in the drug shall not be used for food.

FDA page: Open in Animal Drugs @ FDA

Species: Poults 1 to 3 Day Old • 1 day old chicks

Chickens

Indication

For the prevention of early mortality in day-old chickens associated with Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa susceptible to gentamicin sulfate.

Dosage

0.2 milligram of gentamicin per 0.2 milliliter dose.

Limitations

Turkeys

Indication

As an aid in the prevention of early mortality of 1 to 3-day-old turkeys associated with Arizona paracolon infections susceptible to gentamicin sulfate.

Dosage

One (1) milligram of gentamicin per 0.2 milliliter dose.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: 1 to 3 days old

Composition / specifications

Each milliliter of sterile aqueous solution contains the equivalent of 5 milligrams of gentamicin.

Swine

Indication

In piglets up to 3 days old for treatment of porcine colibacillosis caused by strains of E. coli sensitive to gentamicin

Dosage

5 milligrams of gentamicin as a single intramuscular dose using 5 milligram-per-milliliter solution.

Limitations

For single intramuscular dose in pigs up to 3 days of age only. Do not slaughter treated animals for food for at least 40 days following treatment

FDA page: Open in Animal Drugs @ FDA

Species: Neonate or suckling

Composition / specifications

Each milliliter of pig pump oral solution contains gentamicin sulfate equivalent to 5 milligrams of gentamicin.

Swine (neonatal, 1 to 3 days of age)

Indication

For the control and treatment of colibacillosis in neonatal pigs 1-3 days of age, caused by strains of E. coli sensitive to gentamicin.

Dosage

Administer 1 mL of pig pump oral solution (5 mg of gentamicin) orally per pig one time.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog • Cat

Composition / specifications

Each gram of sterile ointment contains gentamicin sulfate equivalent to 3 milligrams of gentamicin.

Dogs

Indication

The drug is used for topical treatment of conjunctivitis caused by susceptible bacteria.

Dosage

Apply approximately a 1/2 inch strip to the affected eye 2 to 4 times a day.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cats

Indication

The drug is used for topical treatment of conjunctivitis caused by susceptible bacteria.

Dosage

Apply approximately a 1/2 inch strip to the affected eye 2 to 4 times a day.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Composition / specifications

Each gram of gentamicin sulfate soluble powder contains gentamicin sulfate equivalent to 333.3 milligrams of gentamicin. 120 grams of gentamicin per 360 gram jar.

Swine (weanling)

Indication

For the control and treatment of colibacillosis in weaning swine caused by strains of Escherichia coli sensitive to gentamicin.

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Swine

Indication

For the control and treatment of swine dysentery associated with Treponema hyodysenteriae.

Dosage

For proportioner use, add 1 level scoop to 1 gallons stock solution and dispense at the rate of 1 oz/gal drinking water (50 mg/gal).

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

FDA page: Open in Animal Drugs @ FDA

Species: Weanling

Composition / specifications

Each gram of gentamicin sulfate soluble powder contains gentamicin sulfate equivalent to 333.3 milligrams of gentamicin.

Swine (weanling)

Indication

For control and treatment of colibacillosis in weanling swine caused by strains of Escherichia coli sensitive to gentamicin.

Dosage

Administer gentamicin sulfate equivalent to 25 milligrams of gentamicin per gallon of drinking water to provide 0.5 milligram per pound of body weight per day for 3 consecutive days.

Limitations

Swine

Indication

For control and treatment of swine dysentery associated with Brachyspira hyodysenteriae.

Dosage

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

FDA page: Open in Animal Drugs @ FDA

Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

FDA page: Open in Animal Drugs @ FDA

Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses (mares)

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption

FDA page: Open in Animal Drugs @ FDA

Species: Horse

Composition / specifications

Each milliliter of the drug contains 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption.

FDA page: Open in Animal Drugs @ FDA

Species: Horse

Composition / specifications

Each milliliter of the drug contains 50 or 100 milligrams of gentamicin (as the sulfate) in sterile aqueous solution.

Horses

Indication

Dosage

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in horses intended for human consumption

FDA page: Open in Animal Drugs @ FDA

Usage

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive

Loss of appetite (1) • Cat Diarrhea (1) • Cat Decreased appetite (1) • Cat Bloody diarrhoea (1) • Cat Blood in vomit (1) • Cat

Showing top 5 for Digestive.

Skin & allergy

Facial swelling (possible allergy) (1) • Dog Chewing - pruritus (1) • Dog

Showing top 5 for Skin & allergy.

Other

Fluid in abdomen NOS (1) • Dog Eosinophilia (1) • Dog Eosinopenia (1) • Dog Enlarged lymph node (1) • Dog Elevated total bilirubin (1) • Dog

Show more (20)

Elevated serum alkaline phosphatase (1) • Dog Elevated globulins (1) • Cat Elevated cholesterol (1) • Dog Elevated blood urea nitrogen (1) • Dog Elevated bile acids (1) • Dog Elevated alanine aminotransferase (1) • Dog Ear pain (1) • Cat Ear infection NOS (1) • Cat Ear canal inflammation (1) • Dog Decreased red blood cell count (1) • Dog Death by euthanasia (1) • Dog Cystitis (1) • Dog Crust (1) • Dog Cough (1) • Dog Basophilia (1) • Dog Application site scratching (1) • Dog Administration error NOS (1) • Cat Abscess NOS (1) • Cat Abnormal ultrasound finding (1) • Dog Abnormal radiograph finding (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Retriever - Labrador, Female, 4 year, 33.75 kilogram • Drug: MSK, Unknown • Reactions: Vomiting bile • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2026-US-013719
Serious AE: No
Treated For AE: No
Sex: Female
Age: 4.00 Year
Weight: 33.750 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Vomiting bile

Outcomes: Recovered/Normal

Dog, ['Retriever - Golden', 'Poodle - Standard'], Unknown, 1.08 year, 25.49 kilogram • Drug: MSK, Oral • Reactions: Cough, Heavy breathing, Respiratory sound, Abnormal radiograph finding, Eosinophilia… • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-008429
Serious AE: No
Treated For AE: Yes
Sex: Unknown
Age: 1.08 Year
Weight: 25.490 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral

Reactions Reported:

Cough Heavy breathing Respiratory sound Abnormal radiograph finding Eosinophilia Lymphopenia Basophilia Monocytosis

Outcomes: Ongoing

Dog, ['Retriever - Labrador', 'Crossbred Canine/dog'], Male, 2.25 year • Drug: MSK, Unknown • Reactions: Diarrhea, Lack of efficacy (endoparasite) - heartworm, Otitis NOS, Cystitis, Crust… • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2026-US-008762
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 2.25 Year

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Diarrhea Lack of efficacy (endoparasite) - heartworm Otitis NOS Cystitis Crust Itching

Outcomes: Outcome Unknown

Cat, Domestic Shorthair, Male, 7.07 year, 6.26 kilogram • Drug: MSK, Topical • Reactions: Other abnormal test result NOS, Lack of efficacy - NOS • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-071515
Serious AE: No
Treated For AE: No
Sex: Male
Age: 7.07 Year
Weight: 6.260 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Topical

Reactions Reported:

Other abnormal test result NOS Lack of efficacy - NOS

Outcomes: Ongoing

Dog, ['Retriever - Labrador', 'Dog (unknown)'], Male, 12 year, 17.69 kilogram • Drug: MSK, Unassigned, Topical • Reactions: Vomiting, Not eating, Weight loss, Icterus, Leucopenia NOS… • Outcome: Euthanized

Report ID: USA-USFDACVM-2025-US-071623
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 12.00 Year
Weight: 17.690 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Topical
Form: Unassigned

Reactions Reported:

Vomiting Not eating Weight loss Icterus Leucopenia NOS Decreased red blood cell count Thrombocytopenia Elevated alanine aminotransferase Elevated serum alkaline phosphatase Elevated total bilirubin High pancreatic-specific lipase Urinary incontinence Infectious disease NOS Overdose Gall bladder & bile duct disorder NOS Lymphopenia Neutropenia Splenomegaly Loose stool Pancreas disorder Hepatomegaly Death by euthanasia Hypoalbuminaemia Hypoproteinaemia Fluid in abdomen NOS Elevated blood urea nitrogen Elevated bile acids Abnormal ultrasound finding Elevated cholesterol Enlarged lymph node Reduced globulins Monocytopenia Eosinopenia Liver nodules

Outcomes: Euthanized

Dog, Retriever - Labrador, Female, 8.75 year, 30.11 kilogram • Drug: MSK, Unknown • Reactions: Lying down, Sedation, Tongue protrusion • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-068370
Serious AE: Yes
Treated For AE: No
Sex: Female
Age: 8.75 Year
Weight: 30.110 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Lying down Sedation Tongue protrusion

Outcomes: Ongoing

Dog, Shepherd Dog - German, Female, 4 year, 27.66 kilogram • Drug: MSK, Spray, Unknown • Reactions: Licking at injection site, Injection site pain, Injection site lump, Injection site erythema, Injection site alopecia… • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-063395
Serious AE: No
Treated For AE: Yes
Sex: Female
Age: 4.00 Year
Weight: 27.660 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Spray

Reactions Reported:

Licking at injection site Injection site pain Injection site lump Injection site erythema Injection site alopecia Lameness Injection site crust Injection site abscess Injection site reaction NOS

Outcomes: Ongoing

Dog, Retriever - Labrador, Male, 2.5 year, 45.359 kilogram • Drug: MSK, Auricular (Otic) • Reactions: Head shake - ear disorder, Lack of efficacy (bacteria) - Ehrlichia, Obesity/adipositas, Lack of efficacy (endoparasite) - heartworm • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2025-US-062121
Serious AE: No
Treated For AE: Yes
Sex: Male
Age: 2.50 Year
Weight: 45.359 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Auricular (Otic)

Reactions Reported:

Head shake - ear disorder Lack of efficacy (bacteria) - Ehrlichia Obesity/adipositas Lack of efficacy (endoparasite) - heartworm

Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

No community reviews yet. Be the first to share your experience.

This medication has not been reviewed by a veterinarian yet.

Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.

Gentamicin Sulfate

Data freshness

Gentamicin Sulfate

Medication Snapshot

Gentamicin Sulfate

Indications / Uses

Warnings / Contraindications

Side Effects

FAQ

What species is this commonly shown for?

Does this usually require a prescription?

What dosage forms are listed?

Related Conditions

Source Transparency

Add to My Pet's Medications

Pet Owner Quick Guide

Next actions

Medication Research Insights

What to know

Evidence tension

Reaction signal map

Species and breed lens

What your vet may verify

What to watch next

Evidence

Vet Fast Scan

Quick Facts

Warnings / Contraindications

Adverse Reactions

Reported case explorer

USA-USFDACVM-2026-US-008429

USA-USFDACVM-2025-US-071623

Grouped by Body System

Most Reported Reactions

Source Documents

Owner handouts

Official label / PI

SPL

FOI

101-862

101-862

Garasol®

Garasol®

Chickens (day-old)

Turkeys (1- to 3-day-old poults)

GentaPoult

GentaPoult Genta-Ject®

Turkeys (1 to 3 day old poults)

Chickens (day-old)

Genta-Ject®

GentaPoult Genta-Ject®

Turkeys (1 to 3 day old poults)

Chickens (day-old)

Gentamicin Sulfate Ophthalmic Solution

Gentamicin Sulfate Ophthalmic Solution

Label highlights

Gentasol

Gentasol

Turkey (eggs)

GentaMed™-P

GentaMed™-P

Chickens

Turkeys

Gentamicin Piglet Injection

Gentamicin Piglet Injection

Swine

Gentamicin Sulfate Pig Pump Oral Solution

Gentamicin Sulfate Pig Pump Oral Solution

Swine (neonatal, 1 to 3 days of age)

Vetro-Gen™ Veterinary Ophthalmic Ointment

Vetro-Gen™ Veterinary Ophthalmic Ointment

Dogs

Cats

GentaMed™

GentaMed™

Swine (weanling)

Swine

Gentamex™ 100

Gentamex™ 100

Horses (mares)